Karyopharm Therapeutics Inc
Open
SectorHealthcare
10.6 6.21
Overview
Share price change
24h
Min
9.59
Max
10.8
Income | 80M -22M |
|---|---|
Sales | 987K 35M |
EPS | -1.24 |
Profit margin | -63.857 |
Employees | 228 |
EBITDA | 8M -9.8M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +29.35% upside |
Market Cap | 19M 218M |
|---|---|
Previous open | 4.39 |
Previous close | 10.6 |
News Sentiment
By Acuity
50%
50%
171 / 342 Ranking in Healthcare
Karyopharm Therapeutics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Karyopharm Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 13 USD 29.35%
High 16 USD
Low 7 USD
Based on 4 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$